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A lot of energy in the field of proteomics is dedicated to the application of challenging 
experimental workflows, which include metaproteomics, proteogenomics, data independent 
acquisition (DIA), non-specific proteolysis, immunopeptidomics, and open modification 
searches. These workflows are all challenging because of ambiguity in the identification 
stage; they either expand the search space and thus increase the ambiguity of identifications, 
or, in the case of DIA, they generate data that is inherently more ambiguous. In this context, 
machine learning-based predictive models are now generating considerable excitement in 
the field of proteomics because these predictive models hold great potential to drastically 
reduce the ambiguity in the identification process of the above-mentioned workflows. 
Indeed, the field has already produced classical machine learning and deep learning models 
to predict almost every aspect of a liquid chromatography-mass spectrometry (LC-MS) 
experiment. Yet despite all the excitement, thorough integration of predictive models in 
these challenging LC-MS workflows is still limited, and further improvements to the modeling 
and validation procedures can still be made. In this viewpoint we therefore point out highly 
promising recent machine learning developments in proteomics, alongside some of the 
remaining challenges.  




Complex proteomics workflows generate more 
identification ambiguity 
Liquid chromatography - mass spectrometry (LC-MS) offers a high-throughput platform for 
the identification and quantification of proteins in a sample [1]. However, LC-MS analysis 
generates large amounts of signal data that require bioinformatics analysis to match these 
signals with peptides and proteins in the proteome, and to elucidate important biological 
processes such as molecular functions, pathways, protein-protein interactions, and signal 
transduction through post-translational modifications [2]. In order to study these biological 
processes, it is important to acquire a picture of the proteome that is as comprehensive as 
possible. However, more than half of the data currently generated by our LC-MS analyses is 
not matched with proteins, leaving a large unexplored gap in our understanding of the 
proteome [3–5]. 
In order to match signals with peptides and proteins, current proteomics search engines 
match sample-generated LC-MS signals with protein sequences from a target proteome 
database that is taken to contain all known proteins expected to be present in that sample 
[6,7]. This target database thus delineates the search space that contains all peptides that can 
potentially match a given LC-MS signal. If this search space does not contain the correct 
peptide for a given signal, a correctly functioning search engine will fail to match the signal. 
However, the search engine could also be led to make a mistake, incorrectly matching the 
signal to a seemingly well-fitting peptide. These false matches are often very hard to 
distinguish from true matches, which is why the search space should always contain all 
peptides that could be present in the sample, even those which are not of interest to the 
researcher [8,9]. Still, peptides could be absent from the search space due to unknown 
proteins, unknown proteoforms, unexpected protein modifications, and/or unconsidered 
enzymatic cleavages. To alleviate these problems, search engines need to consider larger 
search spaces to match more LC-MS signals (and thus obtain a more comprehensive picture 
of the proteome). This strategy forms the basis of proteogenomic searches [10,11], data 
independent searches [12–14], non-specific cleavage searches [15–17], immunopeptide searches 
[18], metaproteomics searches [19], and open modification searches [20–24]. Yet all these 
approaches fall victim to the rapidly increasing issue of ambiguous matches due to the 
increased sequence diversity offered to the search engine [25]. As a result, more than one 
possible match is found for a given signal, and these are often considered equivalent, or as 
near equivalent as to be indistinguishable [26]. This ambiguity leads to a higher uncertainty 
regarding the actual presence of the final (highest ranking) matched peptide in the sample. 




Correctly functioning search engines deal with such uncertainty by raising identification 
thresholds, thus lowering the identification rate [27]. 
Further complicating the identification issue, LC-MS signals, such as tandem MS spectra, are 
likely to contain both extraneous as well as insufficient information for matching with the 
correct biology. This further increases this possible ambiguity between candidate matches.  
Predicting analyte behavior to reduce identification 
ambiguity 
Solving the ambiguity issue is key in obtaining a comprehensive and accurate biological 
interpretation of the proteome. In identification workflows this can be achieved by exploiting 
the information present in the raw LC-MS data to its fullest. This information includes 
observed retention times, collisional cross-section data for ion mobility analyses, and 
precursor (MS1) and fragmentation spectrum (MS2) peak intensities. Unfortunately, most of 
this information is disregarded by the current generation of proteomics search engines. And 
when used, this information typically takes the form of LC-MS libraries built from previous 
observations of these signals [28]. This reliance on prior observation is fundamentally due to 
our limited understanding of the causes of the exact behavior of the analytes that produced 
these signals. Unfortunately, such experimental libraries are quite incomplete and are often 
very specific to a given experimental setup. There is thus a clear knowledge gap in our 
understanding of the signals acquired in our analytical workflows, which researchers have 
been trying to fill using models that predict peptide behavior in LC-MS instruments. Most 
notably, data-driven modeling through machine learning (ML) has been applied very 
successfully to predict peptide behavior, and thus to fill the knowledge gap that stops us 
from using all acquired information to resolve ambiguity in the identification process.  
A comprehensive overview of the different models and ML algorithms that have been 
applied to proteomics data up to 2014 has previously been provided by Kelchtermans et al. 
[29]. In this viewpoint we therefore focus specifically on recent advances in data-driven 
modeling of the LC-MS workflow since then. In general, data-driven LC-MS models learn to 
predict signals from example data obtained from previous experiments. This process of 
training models on observational data is a non-biased and generic way of fitting complex 
relations, which stands in contrast to using prior knowledge with defined rules to fit a model 
[30]. 




However, because of the large amounts of data required to train accurate and broadly 
applicable models [30], the increasing interest in, and effort put into, developing such 
predictive ML models has kept lockstep with the increasingly large amounts of high quality 
data that have become available in public repositories [31,32]. Indeed, the number of monthly 
submissions to proteomics repositories has seen an explosive growth over the past years, 
which in turn means that the amount of high quality data available to scientists is growing at 
a staggering rate as well [33].  
Perhaps most crucially, the availability of data has grown to the point that it has enabled the 
field to use deep learning (DL) approaches [34] instead of the earlier, classical ML algorithms 
like support vector machines (SVMs) [35] or random forests [36]. DL can fit very complex 
relations and can achieve higher performance compared to classical algorithms, but only if 
sufficiently large amounts of data are available to train them (Figure 1). 
Because LC-MS signals and the processes that generate these signals are convoluted and 
complex, there is a clear performance advantage to using DL to predict these signals as 
compared to classical ML algorithms. These DL methods use neural networks as a basis, 
which have undergone significant innovations in the past decade, and which have become 
highly performant in a wide variety of data driven applications [34]. In image classification, for 
instance, DL has shown that such many-layered neural networks can be used to solve 
complex problems [37]. 
While the ability of DL networks to solve complex problems is not yet fully understood, one 
of the main reasons has been ascribed to the depth of the network [37–39]. This depth is 
determined by the number of layers used, where each layer essentially transforms the input 
data into a new representation (i.e. features). This means that the network can learn complex 
features in the data, and essentially removes the step in which the numerical representation 
of the peptide is optimized for the prediction task in traditional ML algorithms. This so-called 
feature engineering step in classical ML algorithms has to be performed up front, is time 
consuming, and typically requires domain knowledge to execute well. Indeed, when the most 
optimal features are not provided to the ML algorithm, it can significantly hamper the final 
performance of such a classical model. It can thus be clear that DL has a considerable 
advantage over classical ML algorithms by its ability to construct its own features on-the-fly, 
a process called end-to-end learning [40]. The caveat is, however, as stated above, that 
learning these more complex features requires a large amount of data (Figure 1). 
Another benefit related to input features are the specialized layers in DL that can handle 
images, audio, and texts as input. Because the numerical representation for these data types 




can be of inconsistent length, their use in some classical ML algorithms requires additional 
processing. DL does not require these additional processing steps as it can use convolutional 
[41] or recurrent layers [42] to analyze such input. These specialized layers can also be applied 
to many proteomics problems, as sequences are essentially text and can be treated as such. 
In DL, the use of such specialized input layers maintains much more of the original structure 
in the data than classical ML algorithms, which are prone to expert interpretation. This in 
turn usually results in better performance of DL models when compared to classical ML. 
 
Figure 1: Conceptual rendering of the impact of growing data set sizes on the performance of classical machine 
learning (red line) compared to deep learning (blue line). For smaller data sets, classical machine learning is often 
still able to outperform deep neural networks, but with increasing training examples the performance converges 
for classical machine learning while a deep neural network keeps improving. Shallower neural networks (green 
line) generally show performance that is in between classical machine learning and deep neural networks. 
  




Virtually every step of LC-MS workflows can now be 
modelled 
 
Figure 2. Overview of a generalized LC-MS workflow with listed examples of classical machine learning (red box) 
and deep learning applications (blue box) at each step. 
A multitude of steps in proteomics LC-MS workflows have been modeled with machine 
learning, both classical and deep (Figure 2). One of the first of these steps is proteolytic 
digestion of proteins to peptides. Multiple models are available that predict whether a site 
in the protein sequence will be enzymatically cleaved. It should be noted that most of these 
models also inherently predict the peptide’s detectability by mass spectrometry. While older 
digestibility/detectability predictors used decision tree ensembles [43,44], current state-of-the-
art predictors employ DL [45,46].  
After enzymatic digestion, LC is often used as a first step to separate peptides based on their 
physicochemical properties. The time it takes for a peptide to elute from an LC-column is 
called the retention time. Some of the first retention time predictors used SVM algorithms 
with physicochemical properties of amino acids as input features [47,48]. The current state-of-
the-art methods use DL with either convolutional or recurrent layers and one-hot-encoding 
for the sequence [49,50]. Integration of retention time prediction mainly concerns the 




validation of peptide-to-spectrum matches (PSMs) and detection of chimeric spectra [51]. In 
addition to modeling the LC, a smaller effort has been put into training models to predict the 
collisional cross section (CCS) of peptides [52,53]. In contrast, the small molecule field has seen 
a multitude of models to predict the CCS already [54–59]. 
The next step in a bottom-up proteomics experiment is the fragmentation of peptides into 
fragment ions. While the mass-to-charge ratios (m/z) of the putative fragment for a given 
peptide can be easily calculated, their intensities follow more complex patterns. Early 
predictors of peptide fragmentation patterns were based on traditional, bottom-up kinetic 
models [60], but soon data-driven methods using decision trees, Bayesian networks, and 
SVMs took over [61–64]. As is the case with the previously mentioned types of predictors, the 
field has recently made a switch to DL implementations, with a plethora of DL peak intensity 
predictors having been published in the last two years [50,65–68].  
As classical proteomics search engines currently do not fully take MS² peak intensities into 
account, these predictors hold great potential to remove ambiguity between correct and 
incorrect PSMs. Indeed, adding such predictions into the identification pipeline can combine 
the increased sensitivity of spectral library searching with the much more comprehensive 
search space offered by database search engines. This, however, requires a complete 
integration of peak intensity prediction into the search engine. Another challenge for current 
state-of-the art peak intensity predictors is the encoding of peptide modifications, as 
modifications can heavily influence peptide fragmentation patterns [62,69]. 
Further applications of machine learning in proteomics mainly pertain to the identification 
of spectra. DeepNovo, for instance, is a deep learning application for de novo spectrum 
identification[70]. Another example is the routinely used post-processing application 
Percolator[71], in which classical search engine-derived PSM scores and metrics are passed 
on to a semi-supervised SVM implementation which improves the separation between true 
and false matches. When adding information from the above mentioned predictors, such as 
MS² peak intensities, this separation can be improved even further [50,72], and even allows the 
development of a completely machine learning-driven search engine [72].  




Challenges for Machine Learning and Deep Learning  
As discussed so far, modeling LC-MS through data-driven machine learning allows the 
exploitation of more of the information that is embedded in LC-MS data. This should help to 
solve the identification ambiguity issue that arises when the search space is expanded, or 
when the LC-MS data is inherently more ambiguous. Many such models have therefore been 
proposed, and the recent introduction of deep learning algorithms has provided the means 
to compute end-to-end models with significant performance gains. Despite these advances, 
implementations of predictive models in proteomics search engines for the identification of 
peptides (and proteins) in a sample is still very limited. Here, we point out a few of the key 
challenges that make this integration non-trivial. 
First, finding the optimally performant architecture for a complex DL model is a decidedly 
non-trivial task. The choice for an architecture is often based on experience with previously 
well-performing architectures on other problems, or on a trial-and-error strategy. Even 
though methods for optimizing this architecture have been proposed [73,74], most of the 
current models in proteomics do not use such a strategy. 
Once a model is trained, it is important that the model is properly validated, otherwise it 
could lead to wrong and missing peptide identifications downstream, in turn resulting in 
potentially incorrect biological interpretations. However, due to the complex nature of many 
state-of-the-art models, validation and evaluation is a non-trivial task. For now, the validation 
is often performed on a random small subset of the initial data set on which the model is 
trained. Ideally, model evaluation is rigorously designed, for example by testing for a wide 
applicability instead of peptides that closely resemble the training set. Even with a properly 
designed validation, many current studies do not go beyond testing the direct predictive 
performance. 
The validation of a model would be less of a problem if the inner workings could be easily 
understood. Again, the complexity of current DL models can mean that these are essentially 
a black box where a peptide goes in one end, and a prediction comes out the other. Even 
though there is an ongoing effort to bring insight into the inner workings of such models [75], 
what the algorithm learns can be incomprehensible to humans. This incomprehensibility 
means that researchers remain cautious to integrate predictive models into their workflows, 
because this would transfer most of the control in identifying a peptide to the model. 
Even when the model is validated with testing data (e.g. a random, preselected subset of the 
data), there are no dedicated benchmark data sets in proteomics that are consistently used 




for evaluating and comparing models. Such a benchmarking set together with specific 
evaluation methodologies should make comparisons between different models transparent 
and fair.  
Furthermore, it is customary to train, validate and test ML models on ground truth data sets. 
All data points within such a ground truth data set are known with complete certainty to be 
correct. Unfortunately, in most applications of ML in proteomics, there is no ground truth 
available. For now, data sets with synthetic peptides can be considered to be the closest 
available alternative [69,76]. Still, acquisition and analysis of synthetic peptides is performed 
with the same methods as the data it should validate. Ideally there would be an evaluation 
technique that is more accurate and does not suffer from the problems present in LC-MS 
workflows, such as peak broadening, competitive ionization, and poor fragmentation leading 
to ambiguity and/or missed identifications. Moreover, peptide synthesis is not a perfect 
process, resulting in the presence of aberrant sequences, and the absence of intended 
sequences. It can also be argued that synthetic peptide samples do not accurately represent 
the complexity of biological samples. The validation capabilities of synthetic peptide data 
therefore remain somewhat limited, and the quest for ground truth data to validate 
proteomics predictions should continue.  
The general applicability of a data set for evaluation purposes is not the only problem, 
however, as models themselves are sometimes only optimized for specific samples, or for 
specific instruments and their specific parameters. For LC retention time prediction this has 
partly been solved by normalizing the objective of the model through calibration with iRT 
peptides [77]. Without calibration, transfer learning has proven to improve performance of 
models trained on smaller data sets [49]. In transfer learning, some of the learned parameters 
from – usually - a larger data set are reused on different data sets to transfer the gained 
experience. For peptide fragmentation spectra, the experimental parameters (e.g. collisional 
energy) have been included as features [50,66], or tailor-made models have been trained for 
specific instruments and workflows, such as isobaric labeling [62]. 
Another clear example of models being limited in their applicability is the issue of protein 
modifications. Most LC-MS prediction models only encode unmodified amino acids and are 
thus unable to generalize for any modification, unless this can be encoded (with sufficient 
examples) as its own entity in the form of a new amino acid. It would therefore make sense 
to switch from encoding amino acids to encoding the chemical properties of amino acids and 
their modified forms instead, as has been done for metabolite retention time prediction [78]. 
These new representations have the potential to become very important in the future, 




because of the increasing popularity of open modification searching where such 
modification-aware predictions are essential.  
Once a model is trained and validated, it still needs to be integrated in complete workflows. 
Up until now, only a few tools integrate predictions from these models [12–14,72,79]. Indeed, 
while the field has been focusing on obtaining highly performant models, the integration of 
such models into usable workflows has not yet received the same attention. It should be 
noted, however, that the exact requirements for, and gains of, the introduction of better 
performing models have not been extensively researched. As a result, while it makes sense 
to further develop more performant models, it would be highly useful to investigate the 
relation between the discovery of novel or improved biological insights and improved model 
performance. In other words, it will be important to see the improvements in identification 
matched to downstream improvements in the biological interpretation of the corresponding 
results. In addition to setting performance targets for future models, such an analysis has 
the important potential to convince researchers of the worth of integrating these models 
into data processing workflows. 
Conclusion 
As the scientific community continues to acquire and analyze ever more LC-MS data, 
progress in extracting knowledge from these acquired data is not increasing at the same rate. 
This is partly due to the inability of search engines to make use of all the acquired data, 
leading to ambiguity in their identifications, especially in the most interesting, but also the 
most challenging, proteomics workflows. We have posited here that a large proportion of 
this ambiguity can likely be solved through integration of performant machine learning 
based models in the identification pipeline. Recently, such highly performant predictive 
models have become possible, largely due to state-of-the-art machine learning techniques 
that capitalize on the vast amounts of available public data through deep neural networks 
known as deep learning approaches. 
Researchers therefore now have access to a large library of different models that can predict 
the behavior of peptide analytes across almost all steps in their LC-MS workflow. However, 
integration of these models into routinely used identification tools remains limited. This is 
partly due to an inability to interpret the model and limited model applicability outside of its 
original context. Furthermore, model evaluation is performed on a variety of data sets 
instead of a single gold standard, which makes a fair comparison between models and 
justifying the choice for a model difficult. Next to the evaluation of the model itself, the 




impact of different models on downstream analysis should get more priority. Ultimately 
these models are developed to improve downstream analysis; the models and their 
predictions are a means to an end. 
In conclusion, the substantial promise that machine learning models hold to remove 
ambiguity in peptide identification will certainly trigger a more pronounced uptake, and we 
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